Abstract:Introduction: Arsenic (As) exposure is associated with lung toxicity and we aim to investigate the effects of arsenic exposure on lung fibrotic changes. Methods: Participants (n= 976) enrolled via a general health survey underwent chest low-dose computed tomography (LDCT), spirometry forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and urinary arsenic examination during 2016 and 2018. Lung fibrotic changes from LDCT were defined. As LtoL , low arsenic levels in both 2016 and 2018; As LtoH , low arsenic in 2016 but high levels in 2018; As HtoL , high arsenic in 2016 but low levels in 2018; As HtoH , high arsenic levels in both 2016 and 2018. Mice exposed to 0. 0.2mg/L, 2 mg/L, 50 mg/L of sodium arsenite (NaAsO 2 ) through drinking water for 12 weeks and 24 weeks were applied for histological analysis. Cultured lung epithelial cells were exposed to NaAsO 2 and the mesenchymal changes were examined. Results: As HtoH increased the risk (OR= 1.65, 95% CI 1.10, 2.49) of Lung fibrotic positive to positive (reference: Lung fibrotic negative to negative ) compared with As LtoL . Moreover, the predicted mean of FVC and FEV1 in As HtoH (−0.09 units, 95% CI: −0.27, −0.09; −0.09 units, 95% CI: −0.17, −0.01) and As LtoH (−0.13 units, 95% CI: −0.30, −0.10; −0.13 units, 95% CI: −0.22, −0.04) was significantly lower than AS LtoL . Significant lung fibrotic changes including the increase of the alveolar septum thickness and collagen fiber deposition were observed upon 2 mg/L NaAsO 2 treatment for 12 weeks, and the damage was dose- and time-dependent. In vitro , sodium arsenite treatment promotes the epithelial-mesenchymal transition (EMT)-like changes of the normal human bronchial epithelial cells, including upregulation of several fibrotic and mesenchymal markers (fibronectin, MMP-2, and Snail) and cell migration. Inhibition of reactive oxygen species (ROS) and MMP-2 impaired the arsenic-induced EMT changes. Administration of a flavonoid, apigenin, inhibited EMT in vitro and pulmonary damages in vivo with the reduction of mesenchymal markers. Discussion: we demonstrated that continued exposure to arsenic causes lung fibrosis in humans and mice. Targeting lung epithelial cells EMT is effective on the development of therapeutic strategy. Apigenin is effective in the inhibition of arsenic-induced pulmonary fibrosis and EMT.

Arsenite-induced Downregulation of Occludin in Mouse Lungs and BEAS-2B Cells Via the ROS/ERK/ELK1/MLCK and ROS/p38 MAPK Signaling Pathways

Arsenic Induces the Expressions of Angiogenesis-Related Factors Through PI3K and MAPK Pathways in SV-HUC-1 Human Uroepithelial Cells.

Sodium Arsenite Induces Cyclooxygenase-2 Expression in Human Uroepithelial Cells Through MAPK Pathway Activation and Reactive Oxygen Species Induction

Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIMEL to attenuate apoptosis in BEAS-2B cells

Imbalanced Immune Responses Involving Inflammatory Molecules and Immune-Related Pathways in the Lung of Acute and Subchronic Arsenic-Exposed Mice.

Arsenite Increases Cyclin D1 Expression Through Coordinated Regulation of the Ca2+/NFAT2 and NF-κB Pathways Via ERK/MAPK in a Human Uroepithelial Cell Line.

Arsenic downregulates tight junction claudin proteins through p38 and NF-κB in intestinal epithelial cell line, HT-29

AP-1 Activation Attenuates the Arsenite-Induced Apoptotic Response in Human Bronchial Epithelial Cells by Up-Regulating HO-1 Expression

Oxidative stress and MAPK involved into ATF2 expression in immortalized human urothelial cells treated by arsenic

Cyclooxygenase-2 induction by arsenite is through a nuclear factor of activated T-cell-dependent pathway and plays an antiapoptotic role in Beas-2B cells.

Arsenic Activates the ER Stress-Associated Unfolded Protein Response via the Activating Transcription Factor 6 in Human Bronchial Epithelial Cells

Inflammatory cytokine COX-2 mediated cell proliferation through increasing cyclin D1 expression induced by inorganic arsenic in SV-HUC-1 human uroepithelial cells

Arsenic exposure and lung fibrotic changes-evidence from a longitudinal cohort study and experimental models

Arsenic trioxide induces expression of BCL-2 expression via NF-κB and p38 MAPK signaling pathways in BEAS-2B cells during apoptosis

Opposed Arsenite-Induced Signaling Pathways Promote Cell Proliferation or Apoptosis in Cultured Lung Cells.

Enhanced GRP78 protein expression via the IRE1α/ASK1/p38 MAPK pathway during As2O3-induced endoplasmic reticulum stress in BEAS-2B cells

Acute Arsenic Exposure Induces Inflammatory Responses and CD4(+) T Cell Subpopulations Differentiation in Spleen and Thymus with the Involvement of MAPK, NF-kB, and Nrf2

Arsenic induces ferroptosis and acute lung injury through mtROS-mediated mitochondria-associated endoplasmic reticulum membrane dysfunction

Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIM EL to attenuate apoptosis in BEAS-2B cells

Nrf2/Keap1 Pathway in Countering Arsenic-Induced Oxidative Stress in Mice after Chronic Exposure at Environmentally-Relevant Concentrations.

Arsenite Induces Apoptosis of Murine T Lymphocytes Through Membrane Raft-Linked Signaling for Activation of C-Jun Amino-Terminal Kinase